906559-60-2

Basic information

• Product Name: (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE
• Synonyms: (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE;(2S,5R)-tert-butyl 2-ethyl-5-Methylpiperazine-1-carboxylate;(2S,5R)-2-Ethyl-5-methyl-1-piperazinecarboxylic acid 1,1-dimethylethyl ester;1-Boc-2(S)-ethyl-5(R)-methylpiperazine acetic acid salt;(2S,5R)-Tert-Butyl 5-Ethyl-2-Methylpiperazine-1
• CAS NO: 906559-60-2
• Molecular Formula: C₁₂H₂₄N₂O₂
• Molecular Weight: 228.33116
• Product Categories: Piperazines
• Mol File: 906559-60-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 297.443°C at 760 mmHg
• Flash Point: 133.689°C
• Appearance: /
• Density: 0.958g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.451
• Storage Temp.: 2-8°C
• PKA: 8.55±0.60(Predicted)
• CAS DataBase Reference: (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE(906559-60-2)
• EPA Substance Registry System: (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE(906559-60-2)

Safety Data

• Hazardous Substances Data: 906559-60-2(Hazardous Substances Data)

Usage

General Description

(2S,5R)-2-ethyl-5-methyl-N-BOC-piperazine is a chemical compound with a specific stereochemistry and functional groups. The compound contains a piperazine ring with an ethyl and a methyl group attached to it, and a BOC (tert-butoxycarbonyl) protecting group on the nitrogen atom. The stereochemistry of the compound is described by the 2S,5R configuration, indicating the specific arrangement of substituents around the piperazine ring. (2S,5R)-2-ETHYL-5-METHYL-N-BOC-PIPERAZINE is commonly used in organic synthesis and pharmaceutical research as a building block for various molecules and drug candidates. It can also be used as a precursor for the synthesis of diverse molecules with piperazine moiety.

InChI:InChI=1/C12H24N2O2/c1-6-10-7-13-9(2)8-14(10)11(15)16-12(3,4)5/h9-10,13H,6-8H2,1-5H3/t9-,10+/m1/s1

Upstream product

• 906810-51-3 (2S,5R)-1-tert-butoxycarbonyl-2-ethyl-5-methylpiperazine acetate 

Downstream Products

• 907208-00-8 C₂₆H₃₄ClN₅O₃ 

Relevant articles and documents

HETEROARYL SUBSTITUTED PYRAZINYL-PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1 and the pharmaceutically acceptable salts, solvates or esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non limiting example(s) include, psoriasis), autoimmune diseases (non limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.g , tuberculoid leprosy), fixed drug eruptions, cutaneous delayed type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.